Target
Coagulation factor VII
Ligand
BDBM50542732
Substrate
n/a
Meas. Tech.
ChEMBL_1987854 (CHEMBL4621401)
IC50
3270±n/a nM
Citation
 Lorthiois, ERoache, JBarnes-Seeman, DAltmann, EHassiepen, UTurner, GDuvadie, RHornak, VKarki, RGSchiering, NWeihofen, WAPerruccio, FCalhoun, AFazal, TDedic, DDurand, CDussauge, SFettis, KTritsch, FDentel, CDruet, ALiu, DKirman, LLachal, JNamoto, KBevan, DMo, RMonnet, GMuller, LZessis, RHuang, XLindsley, LCurrie, TChiu, YHFridrich, CDelgado, PWang, SHollis-Symynkywicz, MBerghausen, JWilliams, ELiu, HLiang, GKim, HHoffmann, PHein, ARamage, PD'Arcy, AHarlfinger, SRenatus, MRuedisser, SFeldman, DElliott, JSedrani, RMaibaum, JAdams, CM Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family Approach. J Med Chem 63:8088-8113 (2020) [PubMed]  Article 
Target
Name:
Coagulation factor VII
Synonyms:
Eptacog alfa | F7 | FA7_HUMAN | Factor VIIa | Factor VIIa (fVIIa) | Proconvertin | SPCA | Thrombin and coagulation factor VII | serum prothrombin conversion accelerator
Type:
Enzyme
Mol. Mass.:
51599.89
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
466
Sequence:
MVSQALRLLCLLLGLQGCLAAGGVAKASGGETRDMPWKPGPHRVFVTQEEAHGVLHRRRRANAFLEELRPGSLERECKEEQCSFEEAREIFKDAERTKLFWISYSDGDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDDQLICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKRNASKPQGRIVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP
  
Inhibitor
Name:
BDBM50542732
Synonyms:
CHEMBL4647925
Type:
Small organic molecule
Emp. Form.:
C26H27NO4
Mol. Mass.:
417.4969
SMILES:
CC(C)c1cc(CCOc2ccccc2C(O)=O)cc(c1)-c1ccc2OC[C@@H](N)c2c1 |r|
Structure:
Search PDB for entries with ligand similarity: